A non‐computer‐dependent prospective review of blood and blood component utilization
- 4 March 1992
- journal article
- review article
- Published by Wiley in Transfusion
- Vol. 32 (3) , 260-265
- https://doi.org/10.1046/j.1537-2995.1992.32392213811.x
Abstract
The effect that a prospective review of blood and blood component utilization had during a 1‐year period at an 850‐bed tertiary‐care teaching hospital is reported. The review process, which has been in operation for 18 years, is based on institutionally developed usage guidelines for blood, fresh‐frozen plasma (FFP), platelets (Plts), and cryoprecipitate (Cryo). The guidelines were developed by the hospital's Transfusion Medicine Committee. The review is initiated by the transfusion service technical personnel when an order is received. Back‐ up support is provided, as needed, by physicians on the service or by those pathology residents taking off‐hour call. They consult with the ordering physician when questions arise as to the appropriateness of an order as it relates to the patient's clinical situation. Screening values used in the initial evaluation of each order are: hematocrit, less than or equal to 27 percent (0.27) for blood; prothrombin time, greater than or equal to 16 seconds, and/or activated partial thromboplastin time, greater than or equal to 60 seconds, for FFP; bleeding time, greater than or equal to 16 minutes and/or a platelet count of 20 to 100 × 10(3) per mm3 (20‐100 × 10(9)/L), as related to clinical conditions, for Pits; and fibrinogen less than or equal to 120 mg per dL (1.2 g/L) for Cryo. Also taken into consideration is the stated clinical indication, which is provided when the requisition is submitted. As a result of the prospective review, orders for blood and/or components for 114 patients were canceled, and 51 patients received 207 blood components that were more appropriate for the clinical situation. A total of 316 homologous donor exposures were avoided during the year surveyed. A total reduction in patient medical costs of $22,000 was realized as a result of canceled orders, a decrease in the number of units transfused, or the selection of a more appropriate component for transfusion.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 8 references indexed in Scilit:
- The Use of LIS for Blood Usage Review: Experience in a Children's HospitalAmerican Journal of Clinical Pathology, 1991
- A Commentary on Three Consensus Development Conferences on Transfusion MedicineAnesthesiology Clinics of North America, 1990
- Perioperative Red Blood Cell TransfusionPublished by American Medical Association (AMA) ,1988
- Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patientBritish Journal of Haematology, 1987
- Platelet Transfusion TherapyPublished by American Medical Association (AMA) ,1987
- Fresh-Frozen PlasmaPublished by American Medical Association (AMA) ,1985
- Treatment of the Bleeding Tendency in Uremia with CryoprecipitateNew England Journal of Medicine, 1980
- Hemostasis in Massively Transfused Trauma PatientsAnnals of Surgery, 1979